alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 31.1**

 

**CERTIFICATION**

 

I, Sal Perisano, certify that:

 

1.                                       Ihave reviewed this quarterly report on Form 10-Q of iParty Corp.;

 

2.                                       Basedon my knowledge, this report does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statementsmade, in light of the circumstances under which such statements were made, notmisleading with respect to the period covered by this report;

 

3.                                       Basedon my knowledge, the financial statements, and other financial informationincluded in this report, fairly present in all material respects the financialcondition, results of operations and cash flows of the registrant as of, andfor, the periods presented in this report;

 

4.                                       Theregistrant’s other certifying officer and I are responsible for establishingand maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have:

 

a) Designed such disclosure controls andprocedures, or caused such disclosure controls and procedures to be designedunder our supervision, to ensure that material information relating to theregistrant, including its consolidated subsidiaries, is made known to us byothers within those entities, particularly during the period in which thisreport is being prepared;

 

b) [Paragraph omitted in accordance with theSEC transition instructions contained in SEC Release 34-47986];

 

c) Evaluated the effectiveness of theregistrant’s disclosure controls and procedures and presented in this reportour conclusions about the effectiveness of the disclosure controls andprocedures, as of the end of the period covered by this report based on suchevaluation; and

 

d) Disclosed in this report any change in theregistrant’s internal control over financial reporting that occurred during theregistrant’s most recent fiscal quarter that has materially affected, or isreasonably likely to materially affect, the registrant’s internal control overfinancial reporting; and

 

5.                                       Theregistrant’s other certifying officer and I have disclosed, based on our mostrecent evaluation of internal control over financial reporting, to theregistrant’s auditors and the audit committee of registrant’s board ofdirectors (or persons performing the equivalent functions):

 

a) All significant deficiencies and materialweaknesses in the design or operation of internal control over financialreporting which are reasonably likely to affect the registrant’s ability torecord, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, thatinvolves management or other employees who have a significant role in theregistrant’s internal control over financial reporting.

 

 
| Date: May 9, 2004 |
|------------------------|
|                   | /s/ SAL PERISANO |   |
|                   | Sal Perisano |
|                   | Chief Executive Officer |

 

----
# EUR-Lex - 32005M3952 - EN

Important legal notice

*|*

# 32005M3952

**Commission Decision of 19/09/2005 declaring a concentration to be compatible with the common market (Case No IV/M.3952 - SYSTEM CAPITAL MANAGEMENT - METINVEST / LEMAN COMMODITIES) according to Council Regulation (EEC) No 4064/89 (Only the English text is authentic) **

*

*

| |Brussels, 19/09/2005

SG-Greffe(2005) D/205132/3

To the notifying parties

Dear Madam(s) and/or Sir(s),

Subject : Case No. COMP/M.3952 - SYSTEM CAPITAL MANAGEMENT-METINVEST/LEMAN COMMODITIES Notification of 23/08/2005 pursuant to Article 4 of Council Regulation (EC) No. 139/2004 [1] Publication in the Official Journal of the European Union No. C 211, 30/08/2005, page 3

1. On 23/08/2005, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 by which the undertaking Metinvest B.V. (Metinvest, The Netherlands) controlled by System Capital Management (SCM, Ukraine) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Leman Commodities S.A. (Leman, Switzerland) by way of purchase of shares.

2. The business activities of the undertakings concerned are:

- for Metinvest: active in the financing and participation in other companies, some of which are active in the steel sector.

- for SCM: conglomerate company primarily active in the steel sector; other activities include operations in the telecoms, energy generation, shipping, finance and insurance and breweries.

- for Leman: active primarily in the trading steel sector.

3. After examination of the notification, the Commission has concluded that the notified operation falls within the scope of Council Regulation (EC) No. 139/2004 and of paragraph 5, subparagraph c of the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No. 139/2004[2].

4. For the reasons set out in the Notice on a simplified procedure, the Commission has decided not to oppose the notified operation and to declare it compatible with the common market and with the EEA Agreement. This decision is adopted in application of Article 6(1)(b) of Council Regulation (EC) No. 139/2004.

For the Commission

(signed)Neelie KROES Member of the Commission

[1] OJ L 24, 29.1.2004 p. 1

[2] OJ C 56, 05.3.2005 p.32

MERGER PROCEDURE

ARTICLE 6(1)(b) DECISION

SIMPLIFIED PROCEDURE

PUBLIC VERSION
#### Taylor BURNEY, Appellant, v. STATE of Florida, Appellee.

No. 69-631.

District Court of Appeal of Florida, Fourth District.

Feb. 8, 1971.

Appeal from Criminal Court of Record, Palm Beach County; Russell H. McIntosh, Judge.

Appeal dismissed.
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-K

Annual Report Pursuant to Section 13
or 15(d) of the Securities Exchange Act of 1934
for the fiscal year ended December 31, 1999

Commission File Number: 333-24489

Mortgage Capital Funding, Inc. issuer in respect of
Multifamily/Commercial Mortgage Pass-Through Certificates
Series 1998-MC3
(Exact Name of registrant as specified in its charter)

Delaware      			13-3408716
(State or Other Juris-		(I.R.S. Employer
diction of Incorporation)     Identification No.)

399 Park Avenue, New York, NY 10043
(Address of Principal Executive Office)

212-559-6899
(Registrant's telephone number, including area code)


Securities registered pursuant to Section 12(b) of the
Act:     None

Securities registered pursuant to Section 12(g) of the
Act:     None

Indicate by check mark whether the registrant (1) has filed all
reports required to be filed  by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to
file such reports), and (2) has been subject to such filing
requirements for the past 90 days.

Yes  X   No _

Indicate by check mark if disclosure of delinquent filers
pursuant to Item 405 of Regulation S-K is not contained herein,
and will not be contained, to the best of registrant's
knowledge, in definitive proxy or information statements
incorporated by reference in part III of this Form 10-K or any
amendment to this Form 10-K.

Not applicable.

Aggregate market value of voting stock held by non-affiliates of
the Registrant as of December 31, 1999.

Not applicable.

Number of shares of common stock outstanding as of December 31,
1999.

Not applicable.
null

166.66968
[Federal Register Volume 62, Number 200 (Thursday, October 16, 1997)]
[Notices]
[Pages 53788-53789]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-27445]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meeting

    Pursuant of Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting that is being held to review grant applications:

Health Promotion and Disease Prevention Initial Review Group

[[Page 53789]]



--------------------------------------------------------------------------------------------------------------------------------------------------------
     Study Section/Contact Person          November 1997 Meeting                 Time                                    Location                       
--------------------------------------------------------------------------------------------------------------------------------------------------------
Epidemiology & Disease Control-2, Dr.   Nov. 17-19.................  8:30 a.m...................  Embassy Suites Hotel, Chevy Chase Pavilion,           
 Paul Strudler, 301-435-1716.                                                                      Washington, DC.                                      
--------------------------------------------------------------------------------------------------------------------------------------------------------

    The meeting will be closed in accordance with the provisions set 
forth in sections 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. 
Applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Program Nos. 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: October 9, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-27445 Filed 10-15-97; 8:45 am]
BILLING CODE 4140-01-M
----

|   | · | Key                  Technology Holdings USA LLC, an Oregon limited liability                  company |
|--------|--------|--------------------------------------------------------------------------------------------------------|

|   | · | Suplusco                  Holding B.V., a Netherlands                  corporation |
|--------|--------|------------------------------------------------------------------------------------|

|   | · | Key                  Technology B.V., a Netherlands                  corporation |
|--------|--------|----------------------------------------------------------------------------------|

|   | · | Key                  Technology AMVC LLC, an Oregon limited liability                  company |
|--------|--------|------------------------------------------------------------------------------------------------|

|   | · | Key                  Technology Australia Pty. Ltd. |
|--------|--------|-----------------------------------------------------|

|  | · | Freshline                  Machines Pty. Ltd. |
|--|--------|-----------------------------------------------|

|   | · | Productos                  Key Mexicana S. de R.L. de                  C.V. |
|--------|--------|-----------------------------------------------------------------------------|

----
TREATIES AND OTHER INTERNATIONAL ACTS SERIES 10-525 

________________________________________________________________________ 

EDUCATION 

Cooperation 

 Agreement Between 

the UNITED STATES OF AMERICA 

and CHINA 

Signed at Beijing May 25, 2010 
 NOTE BY THE DEPARTMENT OF STATE 

 Pursuant to Public Law 89—497, approved July 8, 1966 

(80 Stat. 271; 1 U.S.C. 113)—

“. . .the Treaties and Other International Acts Series issued 

under the authority of the Secretary of State shall be competent 

 evidence . . . of the treaties, international agreements other than 

treaties, and proclamations by the President of such treaties and 

international agreements other than treaties, as the case may be, 

therein contained, in all the courts of law and equity and of maritime 

jurisdiction, and in all the tribunals and public offices of the 

United States, and of the several States, without any further proof 

or authentication thereof.” 
CHINA 

Education: Cooperation 

 Agreement signed at Beijing May 25, 2010; 

 Entered into force May 25, 2010.
#### STATE of Louisiana ex rel. Claude Woods and Joseph WOODS v. Ross MAGGIO, Jr., Warden, Louisiana State Penitentiary.

No. 60596.

Supreme Court of Louisiana.

Nov. 11, 1977.

In re: Claude Woods and Joseph Woods applying for writ of habeas corpus. Writ denied. The transcribed contemporaneous colloquy of March 22, 1972 shows that the defendants’ guilty pleas were voluntarily made, with full awareness of the consequences., The allegations to the contrary, and of inadequate assistance of counsel, do not, under the circumstances, show that the petitioners are entitled to an evi-dentiary hearing.
Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Hooker Furniture Corporation (the Company) Quarterly Report on Form 10-Q for the period ending July 29, 2007 as filed with the Securities and Exchange Commission on the date hereof (the
Report), I, Paul B. Toms, Jr., Chief Executive Officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
| | --- | ---------------------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                        |  |  |  |     |  |                                      |  | 
|----------------------- |  |  |  | --- |  | ------------------------------------ |  | 
|Date: September 6, 2007 |  |  |  | By: |  | /s/ Paul B. Toms, Jr.                |  | 
|                        |  |  |  |     |  | Paul B. Toms, Jr.                    |  | 
|                        |  |  |  |     |  | Chairman and Chief Executive Officer
##### 



Exhibit 31

Certification of Principal Executive Officer and Principal Financial Officer
Required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934,
as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Thomas M. Donnelly, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Net Perceptions, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of
a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the registrant
as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
registrant and have:

(a) Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under my supervision,
to ensure that material information relating to the registrant, including
its consolidated subsidiaries, is made known to me by others within those
entities, particularly during the period in which this report is being
prepared;

(b) [Paragraph omitted in accordance with SEC transition instructions]

(c) Evaluated the effectiveness of the registrants disclosure controls
and procedures and presented in this report my conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of
the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrants internal
control over financial reporting that occurred during the registrants
most recent fiscal quarter (the registrants fourth fiscal quarter in the
case of an annual report) that has materially affected, or is reasonably
likely to materially affect, the registrants internal control over
financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control
over financial reporting, to the registrants auditors and the audit committee
of the registrants board of directors (or persons performing the equivalent
functions):

(a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrants ability to record,
process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrants internal
control over financial reporting.

Date: November 14, 2003



| | /s/ Thomas M. Donnelly     Thomas
M. Donnelly     President
and     Chief
Financial Officer
| | -------------------------------------------------------------------------------------------
#### James P. COUSINS v. The LUMMUS COMPANY and the Travelers Insurance Co.

No. 62001.

Supreme Court of Louisiana.

May 12, 1978.

In re: James P. Cousins, applying for certiorari, or writ of review, to the Court of Appeal, Fourth Circuit. Parish of Plaque-mines. 355 So.2d 629.

*641Writ granted.

It is ordered that the writ of review issue; that the Court of Appeal send up the record in duplicate of the case; and that counsel for plaintiff and defendant be notified.
[Federal Register Volume 62, Number 201 (Friday, October 17, 1997)]
[Notices]
[Page 54116]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-27568]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Hospital Infection Control Practices Advisory Committee Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting.
    Name: Hospital Infection Control Practices Advisory Committee 
(HICPAC).
    Times and Dates: 8:30 a.m.-5 p.m., November 17, 1997 and 8:30 a.m.-
1 p.m., November 18, 1997.
    Place: Centers for Disease Control and Prevention, Building 16, 
Room 1107/1107A, 1600 Clifton Road, NE, Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available. In 
addition to the Committee, the room will accommodate approximately 25 
guests.
    Purpose: The Committee is charged with providing advice and 
guidance to the Secretary, the Assistant Secretary for Health, the 
Director, CDC, and the Director, National Center for Infectious 
Diseases (NCID), regarding (1) the practice of hospital infection 
control; (2) strategies for surveillance, prevention, and control of 
nosocomial infections in U.S. hospitals; and (3) updating guidelines 
and other policy statements regarding prevention of nosocomial 
infections.
    Matters to be Discussed: Agenda items will include an overview of 
Strategic Direction of HICPAC; a review of the public response to the 
Draft Guideline for Infection Control in Hospital Personnel; a review 
of the second draft of the Guideline for Prevention of Surgical Site 
Infections; and a review of CDC activities of interest to the 
Committee.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Michele L. Pearson, M.D., 
Medical Epidemiologist, Investigation and Prevention Branch, Hospital 
Infections Program, NCID, CDC, 1600 Clifton Road, NE, M/S E-69, 
Atlanta, Georgia 30333, telephone 404/639-6413.

    Dated: October 8, 1997.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 97-27568 Filed 10-16-97; 8:45 am]
BILLING CODE 4l63-l8-P
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM MARCH 31,
2000 FORM 10-Q AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999             DEC-31-2000
<PERIOD-START>                             JAN-01-1999             JAN-01-2000
<PERIOD-END>                               MAR-31-1999             MAR-31-2000
<CASH>                                          58,429                 121,652
<SECURITIES>                                         0                  13,008
<RECEIVABLES>                                   16,687                  17,046
<ALLOWANCES>                                     (142)                 (1,653)
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                                76,049                 157,670
<PP&E>                                               0                       0
<DEPRECIATION>                                   (142)                 (3,680)
<TOTAL-ASSETS>                                  84,070                 200,616
<CURRENT-LIABILITIES>                           24,687                  36,424
<BONDS>                                              0                       0
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                         27                       0
<COMMON>                                            14                      89
<OTHER-SE>                                      52,660                 107,979
<TOTAL-LIABILITY-AND-EQUITY>                    84,070                 200,616
<SALES>                                          6,580                  21,500
<TOTAL-REVENUES>                                 6,580                  21,500
<CGS>                                              318                   2,841
<TOTAL-COSTS>                                      318                   2,841
<OTHER-EXPENSES>                                     0                       0
<LOSS-PROVISION>                                    15                   1,043
<INTEREST-EXPENSE>                                   0                     833
<INCOME-PRETAX>                                (6,824)                (13,924)
<INCOME-TAX>                                      (52)                    (47)
<INCOME-CONTINUING>                            (6,876)                (13,783)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                   (6,876)                (13,783)
<EPS-BASIC>                                     (0.35)                  (0.16)
<EPS-DILUTED>                                   (0.35)                  (0.16)



</TABLE>